U.S. Emerging Insulin Delivery Technologies Markets
U.S. Emerging Insulin Delivery Technologies Markets
RELEASE DATE
23-Apr-2004
23-Apr-2004
REGION
North America
North America
Research Code: A742-01-00-00-00
SKU: HC00957-NA-MR_04812
$3,950.00
Special Price $2,962.50 save 25 %
In stock
SKU
HC00957-NA-MR_04812
Description
This report analyzes the U.S. emerging insulin delivery technologies market, for the forecast period 2000 to 2010. The report is segmented into 6 chapters viz Executive Summary, Total Market, Injectable Insulin, Insulin Pumps, Inhalable Insulin, Oral Insulin and Other Emerging Technologies. Each segment provides revenue forecasts, market share,pricing trends,demand analysis,competitive structure and market and technology trends. Drivers, restraints and challenges and the strategic recommendations are also discussed.The Frost & Sullivan Awards are conferred on deserving companies.
Table of Contents
Executive Summary
- Executive Summary
Report Scope & Segmentation
- Scope and Methodology
- Market Segmentation
Market Overview
- Introduction
- Market Engineering Measurements
- Challenges
Market Demand & Forecasts
- Demand Analysis
- Patient Forecasts
- Revenue Forecasts
Competitive Analysis
- Competitive Structure
- Pipeline Analysis
- Total Market Share
Mergers and Acquisitions
- Disetronic and Roche Diagnostics
- Equidyne Becomes Injex
- Generex and Eli Lilly Dissolve Partnership
- Eli Lilly and BD Partners
Frost & Sullivan Awards
- Technology Excellence Award
- Growth Strategy Award
- Patient Compliance Enhancement Strategy Award
Segment Highlights
Insulin Syringes Market
Insulin Pens Market
Jet Injectors Market
Segment Highlights
Overview
Competitive Analysis
Segment Highlights
Overview
Product and Technology Analysis
Segment Highlights
Oral Insulin Market
Other Emerging Insulin Delivery Technologies
Decision Support Database
This report analyzes the U.S. emerging insulin delivery technologies market, for the forecast period 2000 to 2010. The report is segmented into 6 chapters viz Executive Summary, Total Market, Injectable Insulin, Insulin Pumps, Inhalable Insulin, Oral Insulin and Other Emerging Technologies. Each segment provides revenue forecasts, market share,pricing trends,demand analysis,competitive structure and market and technology trends. Drivers, restraints and challenges and the strategic recommendations are also discussed.The Frost & Sullivan Awards are conferred on deserving companies.
No Index | Yes |
---|---|
Podcast | No |
Industries | Healthcare |
WIP Number | A742-01-00-00-00 |
Is Prebook | No |